About GondolaBio
GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio aims to leverage cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases.
Who You Are
You are an experienced regulatory affairs professional with expertise in early clinical development and a strong track record of advancing innovative therapies through key regulatory milestones. You are comfortable leading regulatory strategy for one or more development programs while partnering closely with cross-functional teams in a small, fast-moving biotech environment.
You thrive at the intersection of science, clinical development, and regulatory execution, bringing a pragmatic, solutions-oriented mindset to navigating complex regulatory pathways, including those relevant to rare diseases and accelerated development. You are equally comfortable developing strategy and driving execution, ensuring that regulatory plans are aligned with program objectives and business priorities.
Key Responsibilities
Job details are sourced from the employer's original posting.
Open job postingAbout the company
This company is involved in clinical pharmacology and early clinical development, focusing on early clinical sciences and development strategy from first-in-human through Phase 2. They also lead quantitative sciences including data analytics, pharmacometrics, biostatistics, and data management to inform dose selection and program development.